First-in-Human Transcatheter Pulmonic Valve Implantation Through a Tricuspid Valve Bioprosthesis to Treat Native Pulmonary Valve Regurgitation Caused by Carcinoid Syndrome

Transcatheter heart valve implantation is a well-established alternative to surgical valve replacement for specific types of valvular heart disease [(1–4)][1]. We report the first case of implantation of an Edwards SAPIEN XT transcatheter heart valve (Edwards Lifesciences, Irvine, California) in